GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (OTCPK:GTBIF) » Definitions » Beneish M-Score

GTBIF (Green Thumb Industries) Beneish M-Score : -2.45 (As of Apr. 03, 2025)


View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.45 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Green Thumb Industries's Beneish M-Score or its related term are showing as below:

GTBIF' s Beneish M-Score Range Over the Past 10 Years
Min: -2.76   Med: -2.16   Max: 0.75
Current: -2.45

During the past 13 years, the highest Beneish M-Score of Green Thumb Industries was 0.75. The lowest was -2.76. And the median was -2.16.


Green Thumb Industries Beneish M-Score Historical Data

The historical data trend for Green Thumb Industries's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Thumb Industries Beneish M-Score Chart

Green Thumb Industries Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.48 -2.39 -1.92 -2.76 -2.45

Green Thumb Industries Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.76 -2.24 -2.61 -2.60 -2.45

Competitive Comparison of Green Thumb Industries's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Thumb Industries's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's Beneish M-Score falls into.


;
;

Green Thumb Industries Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Green Thumb Industries for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1549+0.528 * 0.9445+0.404 * 0.9405+0.892 * 1.0783+0.115 * 0.935
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0218+4.679 * -0.044543-0.327 * 0.9646
=-2.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was $54 Mil.
Revenue was 294.323 + 286.865 + 280.147 + 275.806 = $1,137 Mil.
Gross Profit was 158.069 + 147.591 + 150.52 + 144.929 = $601 Mil.
Total Current Assets was $404 Mil.
Total Assets was $2,537 Mil.
Property, Plant and Equipment(Net PPE) was $962 Mil.
Depreciation, Depletion and Amortization(DDA) was $168 Mil.
Selling, General, & Admin. Expense(SGA) was $377 Mil.
Total Current Liabilities was $165 Mil.
Long-Term Debt & Capital Lease Obligation was $504 Mil.
Net Income was 12.679 + 8.616 + 20.712 + 31.076 = $73 Mil.
Non Operating Income was -9.505 + -0.29 + 2.464 + -1.763 = $-9 Mil.
Cash Flow from Operations was 43.338 + 47.671 + 20.151 + 84.023 = $195 Mil.
Total Receivables was $43 Mil.
Revenue was 278.231 + 275.398 + 252.388 + 248.536 = $1,055 Mil.
Gross Profit was 142.688 + 133.806 + 125.28 + 124.721 = $526 Mil.
Total Current Assets was $343 Mil.
Total Assets was $2,490 Mil.
Property, Plant and Equipment(Net PPE) was $925 Mil.
Depreciation, Depletion and Amortization(DDA) was $149 Mil.
Selling, General, & Admin. Expense(SGA) was $342 Mil.
Total Current Liabilities was $126 Mil.
Long-Term Debt & Capital Lease Obligation was $555 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(53.519 / 1137.141) / (42.975 / 1054.553)
=0.047065 / 0.040752
=1.1549

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(526.495 / 1054.553) / (601.109 / 1137.141)
=0.499259 / 0.528614
=0.9445

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (403.9 + 962.295) / 2537.012) / (1 - (342.762 + 925.475) / 2490.057)
=0.461494 / 0.49068
=0.9405

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1137.141 / 1054.553
=1.0783

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(149.021 / (149.021 + 925.475)) / (167.595 / (167.595 + 962.295))
=0.138689 / 0.148329
=0.935

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(376.684 / 1137.141) / (341.863 / 1054.553)
=0.331255 / 0.324178
=1.0218

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((504.342 + 164.969) / 2537.012) / ((554.991 + 126.05) / 2490.057)
=0.263819 / 0.273504
=0.9646

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(73.083 - -9.094 - 195.183) / 2537.012
=-0.044543

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Green Thumb Industries has a M-score of -2.53 suggests that the company is unlikely to be a manipulator.


Green Thumb Industries Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Thumb Industries Business Description

Traded in Other Exchanges
Address
325 West Huron Street, Suite 700, Chicago, IL, USA, 60654
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RYTHM.
Executives
Richard Reisin director 325 W. HURON STREET, SUITE 700, CHICAGO IL 60654
Hannah Scofield Buchan director 660 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10065
Ethan Nadelmann director 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Dawn Wilson Barnes director 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Bret Kravitz officer: GENERAL COUNSEL AND SECRETARY 325 WEST HURON STREET, SUITE 700, CHICAGO IL 60654
Jeffrey H Goldman director 325 W HURON STREET, SUITE 700, CHICAGO IL 60654
Richard A Drexler director 200 S MICHIGAN AVE, SUITE 1300, CHICAGO IL 60604
Dorri Mcwhorter director 6431 OAKTON STREET, C/O LIFEWAY FOODS, INC., MORTON GROVE IL 60053
Swati Mylavarapu director 325 W. HURON ST., SUITE 700, CHICAGO IL 60654
Mathew Faulkner officer: Chief Accounting Officer 325 W. HURON, SUITE 412, CHICAGO IL 60654
Beth Elaine Burk officer: General Counsel 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Benjamin Kovler director, 10 percent owner, officer: Chairman & CEO 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Armen Yemenidjian officer: President 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Jennifer Dooley other: Chief Strategy Officer 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654
Westley Moore director 325 WEST HURON STREET, SUITE 412, CHICAGO IL 60654